Outbreaks, Surveillance and Pandemic Preparedness — Questions

A complete answer confirms the outbreak briefly, then concentrates on practical, RSV-appropriate infection prevention and control, because that is what stops transmission.

a. Confirm the outbreak and define cases. Confirm RSV by polymerase chain reaction, confirm that the number exceeds the expected background, and set a working case definition (a neonate on the unit with a compatible illness and laboratory-confirmed RSV in the period). Use rapid point-of-care testing to identify cases quickly, since prompt detection drives cohorting.

b. Establish the extent. Actively screen all neonates and staff for compatible illness, compile a line listing, and plot cases by onset and cot location to see how far transmission has reached. Keep this brief: it orients control but must not delay it.

c. Institute infection prevention and control (the priority). RSV spreads by respiratory droplets and by contact with secretions on hands, surfaces and shared equipment, so control targets those routes:

• Hand hygiene is the single most effective measure: alcohol-based hand rub before and after every contact, reinforced for staff, parents and visitors.
• Contact and droplet precautions for all cases and contacts: gloves and gowns for hands-on care, surgical mask and eye protection for close or aerosol-generating contact.
• Cohort infected neonates in one area and cohort the nursing staff, so dedicated staff care for infected or for uninfected babies but do not cross between them.
• Exclude symptomatic staff from work and restrict visitors with respiratory symptoms; limit non-essential entry to the unit.
• Environmental cleaning and equipment decontamination: disinfect surfaces and shared items, and dedicate equipment (stethoscopes, monitors, saturation probes) to each cohort.
• Relieve overcrowding and understaffing and ensure adequate spacing between cots, both established risk factors for nosocomial RSV.
• Close the unit to new admissions if transmission continues despite the above.
• Consider RSV monoclonal antibody prophylaxis (palivizumab or nirsevimab) for high-risk exposed neonates per local policy, recognising its role in outbreak control is adjunctive and the evidence limited.

d. Surveillance, communication and closure. Notify the infection prevention and control team and unit management, maintain active surveillance for new cases, educate staff, and declare the outbreak over once no new cases occur for two incubation periods (RSV incubation is about two to eight days).

Notifiable Medical Condition (NMC) reporting is the statutory surveillance system that requires designated conditions to be reported to the public-health authority.

• Legal basis. Reporting is mandatory under national health legislation (in South Africa, the National Health Act), placing a duty on both clinicians and laboratories.
• Categories by urgency. Conditions are graded by how fast they must be reported: the most serious, such as the viral haemorrhagic fevers, measles and acute flaccid paralysis, require immediate notification within 24 hours, while others allow a few days.
• Who reports and how. The attending clinician and the diagnostic laboratory both notify, increasingly through an electronic system that improves completeness and timeliness.
• Purpose. Notification triggers the public-health response (contact tracing, prophylaxis, outbreak control) and feeds national and global surveillance.

Surveillance is often hardest where it is most needed, at the sites where emerging viruses first appear.

• Weak laboratory infrastructure. Limited testing capacity and unreliable supply chains delay or prevent confirmation, and reference testing may be far away.
• Incomplete vital registration. Many deaths go unregistered or uncertified, so mortality data are poor; verbal autopsy is sometimes the only tool.
• Under-reporting. Passive systems capture only a fraction of cases where access to care is low and reporting is not resourced.
• Workforce and funding gaps. Too few trained field epidemiologists and competing priorities limit timely analysis and response.
• Mitigations. Sentinel sites, community-based surveillance, mobile-phone reporting, simple tools and field-epidemiology training programmes extend reach at lower cost.

Surveillance is the ongoing, systematic collection, analysis, interpretation and dissemination of health data, linked to action: “information for action”.

• Systematic and continuous. Data are gathered routinely against a standard case definition, not ad hoc.
• The surveillance cycle. Collection feeds analysis and interpretation, then dissemination, then public-health action, with feedback to the providers of the data; a weak link degrades the whole.
• Fit for purpose. Systems are chosen and judged against attributes that trade off, chiefly sensitivity, timeliness, representativeness and predictive value.
• A clinical trigger plus laboratory confirmation. Effective viral surveillance pairs a syndromic or clinical signal (influenza-like illness, acute flaccid paralysis) with laboratory confirmation and, increasingly, genomic and environmental data.

A case definition is the agreed set of criteria for counting someone as a case, applied consistently throughout an investigation.

• Comparability. A standard definition lets cases be counted the same way across person, place and time, so a rise is real and not an artefact of differing clinical judgement.
• Sensitivity then specificity. Early, suspected definitions are deliberately broad so true cases are not missed; they are tightened to probable and confirmed for the analytic study to reduce misclassification.
• Avoiding bias. When testing an unknown source, the definition must not include the exposure under investigation, or the association becomes circular.
• Triage. Layered definitions also guide who is isolated, treated and tested when capacity is limited.

The laboratory turns clinical suspicion into confirmed fact and links cases that clinical features alone cannot.

• Confirming the agent. Identifying, or excluding, the causative virus verifies that an outbreak is real and establishes what it is.
• Linking cases. Molecular typing and genomic sequencing show whether separate cases share a strain, defining the outbreak’s extent and its transmission chains.
• Early signal. Laboratory-based reporting and reference-laboratory networks often detect an unusual cluster before clinical notification does.
• Guiding response. Strain characterisation informs antiviral susceptibility, vaccine matching and the choice of control measures.

Acute flaccid paralysis (AFP) surveillance is the backbone of polio eradication: every case of sudden floppy weakness is investigated to prove or exclude poliovirus.

• Sensitivity. Detect at least the expected background of non-polio AFP, a target of around 1 to 2 cases per 100,000 children under 15 years, which shows the system finds cases even where polio is absent.
• Completeness and timeliness. Report and investigate every case promptly, with immediate case investigation.
• Adequate stool specimens. Collect two stool samples 24 to 48 hours apart, within 14 days of onset, transported in a cold chain to an accredited laboratory.
• Laboratory confirmation. Test within the WHO-accredited poliovirus laboratory network, with genomic characterisation to distinguish wild, vaccine (Sabin) and vaccine-derived strains.

The WHO Director-General declares a PHEIC, on the advice of an Emergency Committee, under the International Health Regulations (2005). It marks an extraordinary event that risks international spread and may need a coordinated response, and triggers temporary recommendations to member states.

A point-source outbreak follows a single brief common exposure, so all cases appear within one incubation period, giving a sharp rise and fall. The exposure time can be estimated by counting one mean incubation period back from the peak.

An outbreak, used interchangeably with epidemic, is the occurrence of more cases than expected for a given population, place and time, or a single case of something new or of major significance. The steady background level is endemic disease.

At low prevalence the positive predictive value falls, so a larger share of positive results are false. Predictive value depends on prevalence, not only on a test’s sensitivity and specificity, which is why surveillance signals are confirmed before action.

A propagated curve reflects person-to-person, or vector, transmission, each wave infecting the next about one incubation period later. It contrasts with the single sharp peak of a point source.

Quarantine separates people who may be incubating an infection but are not yet ill, while isolation separates those who are already infectious. Quarantine loses value once a disease can travel internationally faster than its incubation period.

Syndromic surveillance monitors symptom patterns before a diagnosis is established, so its strength is timeliness, catching a rise early. The trade-off is low specificity, so signals still need laboratory confirmation.

A case-control study compares the odds of exposure in cases and controls, giving an odds ratio, and is used when there is no enumerable denominator. A cohort study, yielding a relative risk, suits a defined countable population such as everyone at a single event.

In active surveillance health officials take the initiative to obtain reports, giving high completeness and timeliness, but it is resource-intensive and reserved for priority diseases. Passive surveillance is cheaper and wider but under-reports.